select a format

Single User License
USD 2500 INR 161075
Site License
USD 5000 INR 322150
Corporate User License
USD 7500 INR 483225

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Ventricular Fibrillation Global Clinical Trials Review, H1, 2015

Ventricular Fibrillation Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2614CTIDB
  • |
  • Pages: 73
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Ventricular Fibrillation Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Ventricular Fibrillation Global Clinical Trials Review, H1, 2015" provides data on the Ventricular Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Fibrillation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Ventricular Fibrillation 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Ventricular Fibrillation 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Ventricular Fibrillation Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

Baxter International Inc. 26

Clinical Trial Overview of Baxter International Inc. 26

Sanofi 27

Clinical Trial Overview of Sanofi 27

Sandoz International GmbH 28

Clinical Trial Overview of Sandoz International GmbH 28

Ikaria Inc. 29

Clinical Trial Overview of Ikaria Inc. 29

Gilead Sciences, Inc. 30

Clinical Trial Overview of Gilead Sciences, Inc. 30

Gilead Sciences 31

Clinical Trial Overview of Gilead Sciences 31

Clinical Trial Overview of Top Institutes / Government 32

National Heart, Lung, and Blood Institute 32

Clinical Trial Overview of National Heart, Lung, and Blood Institute 32

Assistance Publique-Hopitaux de Paris 33

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 33

Beaumont Health System 34

Clinical Trial Overview of Beaumont Health System 34

Department of Health, UK 35

Clinical Trial Overview of Department of Health, UK 35

Japan Heart Foundation 36

Clinical Trial Overview of Japan Heart Foundation 36

Japan Medical Association 37

Clinical Trial Overview of Japan Medical Association 37

Karolinska Institute 38

Clinical Trial Overview of Karolinska Institute 38

Klinikum der Ludwig-Maximilians-Universitat Munchen 39

Clinical Trial Overview of Klinikum der Ludwig-Maximilians-Universitat Munchen 39

Mayo Clinic 40

Clinical Trial Overview of Mayo Clinic 40

Rajaei Hospital 41

Clinical Trial Overview of Rajaei Hospital 41

Five Key Clinical Profiles 42

Appendix 71

Abbreviations 71

Definitions 71

Research Methodology 72

Secondary Research 72

About GlobalData 73

Contact Us 73

Disclaimer 73

Source 73

List of Figures

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Ventricular Fibrillation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Ventricular Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Ventricular Fibrillation Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Ventricular Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12

Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13

Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Ventricular Fibrillation Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Ventricular Fibrillation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 72

List of Tables

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Region, 2015* 6

Ventricular Fibrillation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Ventricular Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Ventricular Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Ventricular Fibrillation Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Ventricular Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Proportion of Ventricular Fibrillation to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13

Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Ventricular Fibrillation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Ventricular Fibrillation Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Ventricular Fibrillation Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Ventricular Fibrillation Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Ventricular Fibrillation Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Ventricular Fibrillation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Ventricular Fibrillation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 26

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 27

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz International GmbH, 2015* 28

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Inc., 2015* 29

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 30

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2015* 31

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015* 32

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 33

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Beaumont Health System, 2015* 34

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 35

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Heart Foundation, 2015* 36

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Medical Association, 2015* 37

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2015* 38

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Klinikum der Ludwig-Maximilians-Universitat Munchen, 2015* 39

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 40

Ventricular Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Rajaei Hospital, 2015* 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ventricular Fibrillation Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ventricular Fibrillation, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com